Human Platelet Alloantigen (HPA-5) Polymorphism in Sickle Cell Disease Patients with Vaso-Occlusive Crisis
Last updated: 01 Jan 2025
10.21608/mjcu.2019.65647
Sickle cell disease, Vaso-occlusive crisis, HPA, PCR-RFLP
IMAN R. EL-MAHGOUB, M.D.;
AZZA A. ALI, M.D.
AMIRA S.A. FARHAN, M.Sc.;
MONA K. EL-GHAMRAWY, M.D.
HEBATULLLA FAROUK, M.D.;
SOHA ATEF, M.D.
GEHAN H. SHAHIN, M.D.;
RANIA SOLIMAN, M.Sc.
The Department of Clinical & Chemical Pathology, Faculty of Medicine, Cairo University*, National Research Centre** and Pediatric Department, Faculty of Medicine Cairo University***
87
September
8905
2019-09-01
2018-12-20
2019-09-01
3,501
3,506
0045-3803
2536-9806
https://mjcu.journals.ekb.eg/article_65647.html
https://mjcu.journals.ekb.eg/service?article_code=65647
93
Original Article
263
Journal
The Medical Journal of Cairo University
https://mjcu.journals.ekb.eg/
Human Platelet Alloantigen (HPA-5) Polymorphism in Sickle Cell Disease Patients with Vaso-Occlusive Crisis
Details
Type
Article
Created At
22 Jan 2023